Home | Chinese Version
Your current position:English.lf.gov.cn >> Investment Guide >> Key Investment Promotion Projects >> Read Article

2014 LangFang Key Project Introduction - Biological medicine Projects

2014-5-6 14:31:07    Hits:

59. Plasma and Blood Products Centre With an Annual Processing Capacity of 200 Tons
60. The use of animal blood extraction superoxide dismutase project
61. Drug chemical module high-purity reagent production projects
62. The project of Implanting decellularized substrate material of animal origin Project
63. The project of NIP phase controlled embolism materials and series of products research and development projects
64. The project of Raymond Stem Cells Research Center Taiyuan Ryan Cell Therapy R&D Project
65. The project of Stem Cell and Cancer clinical detection kits

 

 


Plasma and Blood Products Centre With an Annual Processing Capacity of 200 Tons
   
Project Content: To cover an area of 80 MU, the Center is designed to process 200 tons of plasma and blood products.
    Investment Estimate and Sources: The total investment amounts to 43.75 million USD, among which 20 million USD will be solicited.
    Market Analysis: Obviously the human plasma and blood product plays an important role in the biological products industry. Human plasma protein products, being processed from the healthy human blood by using the protein separation technique, are widely used in diseases prevention, treatment, and therefore have a great clinical demand.
    Constrcution Conditions: Infrastructure is completed, land leveled and transportation convenient.
    Economic Returns: With sales revenues reaching 35 million UDS, profit 9 million USD, tax 3 million USD.
    Chinese Partner: As a GMP accredited company in China, Forwell Biophram Co., Ltd, mainly specializing in manufacturing prophylactic vaccines for human, is a large pharmaceutical enterprises engaging in vaccines research and developing, manufacturing, sales.
    Cooperation Mode: Cooperation and Partnership
    Contacts:   WANG Rong
    Email: vrabbit@yanjiao.gov.cn
    Tel: 0086-316-3327 823
    Add: 1 Xinggong East Road, Yanjiao Development Zone, Beijing
    Post Code:101601

 

 

The use of animal blood extraction superoxide dismutase project

Investment estimation : The total investment in the USD 12.9 million to and all to be utilized foreign capital.  
Market Analysis : superoxide dismutase, the appearance of powder crystals, non-toxic, soluble in water, medicine, biology, medicine, health supplies, foodstuffs, cosmetics, chemical plays an important practical value. Can remove intimate excessive stress, and enhance human immunity, delayed age; Effectively lowers blood lipid, cholesterol, blood pressure; Anti-fatigue, increase induced functional; Anti-radiation; Diabetes clear to resume; - Female physiological cycles and delay menopause.  
Building conditions : the project sites in Dachang county Dachang town, 40 kilometers away from the center of Beijing, Tianjin 100 km away from areas most convenient communication is very convenient, hydropower facilities
Benefit analysis : Project is completed, the annual sales income 10 million yuan, profits 800 million, 80% profit margins, investment recovery period is one year.  
Cooperation: Wholly investment  
Address: Dachang County Livestock Veterinary Board  
The Faculty : Pang  lianhai 
Call : 0086-316-8952737  
Postcode : 065300 

 


Drug chemical module high-purity reagent production projects

Project content: project covering 100 mu, large and medium-sized construction of a new biomedical materials and OLED Research Institute, and pilot base.
    Investment estimation: a total investment is USD 80.65 million, USD 16.13 million of funds to introduce.
    Market Analysis: The project involves a large amount of leading international and domestic advanced level of sophisticated biomedical reagents, pharmaceutical intermediates and OLED technology and new materials, to quickly form OLED biomedicine and new materials industry chain, as China's pharmaceutical industry, and new materials for high-speed industrial development and lay a solid foundation.
    Building conditions: The project site in Hebei Province Dachang County Industrial Park in Southern District, 40 kilometers from the center of Beijing, Tianjin, 100 kilometers away from, transport facilities, telecommunications, water and power facilities are available.
    Analysis: After completion of the project, the turnover will reach 400 million yuan and profits of 120 million yuan, 90 million yuan turned over taxes, foreign exchange earned through exports 70 million yuan.
    Cooperation Form: joint ventures, cooperation
    Address: Industrial Park Management Committee Dachang
    The Faculty: Wu Hainan
    Call: 0086-10 - 58205663
    Postcode: 065302

 

The project of Implanting decellularized substrate material of animal origin Project

Project Content: Established in 2012, Beijing Bo Hui Rui Jin bio-tech Company was a biological medicine high-tech enterprise which research, produce and sell high-end medical equipment products, major in boosting R&D of new materials and application of new technology. The company focuses on researching and developing new type of high value-added medical apparatus and instruments like Heterogeneous tissue matrix material, now it has built three purification plants for materials implant, biological dressing and In vitro diagnostic kits. Total built-up area 1000 square meters. With microorganism, technology,  analysis, rationalization and molecular biology laboratories and specialized production equipment and testing equipment like freeze drying machine, the mode of ultrasonic cleaning machine, high performance liquid chromatograph, meteorological chromatographic analyzer etc. which has acquired medical equipment production license.
Investment Estimation and Fund Source: Total investment is 24 million dollars.
Market Analysis:Implanting decellularized substrate material of animal origin Project is still a blank in our country, wide market prospect is predicted. 
Construction Conditions: The project is planned to be constructed in the TaiGu Life Science Park in Guan.
Benefit Analysis: When it goes into operation, there will be 50 million of annual production, 45 million of annual sales and 8 million of revenue.
General Description of Chinese Sponsor: Guan emerging industries demonstration zone is founded by provincial government in March, 2011. In ambition to create industrial clusters of astronautical technology, biological medicine, information technology and High-end Equipment Manufacturing.
Cooperative Form: cooperative
Contact Person: Ren Hong Ying
Tel:18001323858
Fax: 0086-316-5925370 
Address: DaXing biological medicine industrial base, Zhong Guan Cun Science and Technology Park, DaXing District.
Post Code: 102600
E-mail:gaxxcysfq@126.com

 

The project of NIP phase controlled embolism materials and series of products research and development projects

Project Content:  Beijing DeRunJun Science Company is established in 2005, committed to the collaborative research and development, manufacturing, information integration and market analysis of implantable medical apparatus and instruments. It plans to invest in the construction of domestic leading researching laboratory and workshop in the TaiGu Life Science Park in Guan.  
Investment Estimation and Fund Source: 16 million dollars.
Market Analysis:The NIP phase controlled embolism materials and series of products are the only controlled phase transition and non-toxic material in the Tumor involved material field. The first-generation product have made it to the clinic, predicting to launch new products in 2015.The research progress of second-generation product is expected to complete in the end of 2014, and enter the clinical phase ASAP. 
Construction Conditions: The project is planned to be constructed in the TaiGu Life Science Park in Guan, including laboratories, production center, testing center, engineering center and research institute. 
Benefit Analysis: Annual value of 30 million and sales of 25 million and taxes of 5 million are expected when the construction is finished.
General Description of Chinese Sponsor: Guan emerging industries demonstration zone is founded by provincial government in March, 2011. In ambition to create industrial clusters of astronautical technology, biological medicine, information technology and High-end Equipment Manufacturing.
Cooperative Form:  joint-venture or cooperative
Contact Person: Liu Zhen Tao
Tel:15210120488
Fax: 0086-316-5925370 
Address: DaXing biological medicine industrial base, Zhong Guan Cun Science and Technology Park,  DaXing District.
Post Code: 102600
E-mail: gaxxcysfq@126.com

 

The project of Raymond Stem Cells Research Center
 Taiyuan Ryan Cell Therapy R&D Project

Project Content: The researching team of Raymond Stem cells Research center was composed of famous experts and professors from home and abroad. It has undertaken the researching results of 863 and 973 Project and has carried out fundamental research and clinical treatment for 10 years. The team has scored remarkable achievements with patents of the anti-aging effect of stem cells and cosmetic technique and chronic diseases targeted therapy drugs. Authorized by government with independent research and development, It has confirmed its leading position in stem cells industry in the world.
Investment Estimation and Fund Source: 16 million dollars.
Market Analysis:Cellular therapy of Parkinson's disease, using scientific clinical treatment to further validate the clinical effects of hRPE cell has made hRPE cell into injections which will bring joyous news to two millions of Parkinson’s patients in our country. Possessing original intellectual property of stem cells therapy of mental disease, we can gain economic benefits from a one-billion market within a year. This project is of great significance both socially and financially.  
  Autologous bone marrow cell transplantation in the treatment of pneumoconiosis is the leading treatment of pneumoconiosis in the world. It has provided effective methods for prevention and control of pneumoconiosis. With growing number of 750 thousand of Pneumoconiosis patients in our country, this therapy will create huge social and economic benefits.
Construction Conditions: The project is planned to be constructed in the TaiGu Life Science Park in Guan.
Benefit Analysis: 500 people of treatment and 100 million of annual sales are expected when it goes into operation.
General Description of Chinese Sponsor: Guan emerging industries demonstration zone is founded by provincial government in March, 2011. In ambition to create industrial clusters of astronautical technology, biological medicine, information technology and High-end Equipment Manufacturing.
Cooperative Form:  joint venture or cooperative
Contact Person: Li Ming Hao
Tel:15269820684
Fax: 0086-316- 5925370
Address: No.15, Qing nian Road, Ying Ze District ,Taiyaun city
E-mail:gaxxcysfq@126.com


The project of Stem Cell and Cancer clinical detection kits

Project Content: ShaChuan (LangFang) Biological science and technology Development Company is a biotech company that integrates mesenchymal stem cell development, biological diagnosis and R&D of detection reagent. The company owns a large and powerful research team whose members are all accomplished professors in stem cells and Biological detection field.
Investment Estimation and Fund Source:  16 million dollars. Take a variety of ways of cooperation
Construction Conditions: The project is planned to be constructed in the TaiGu Life Science Park in Guan.
Market Analysis:Cooperated with many Top three hospitals, depending on stem cell and functional genomics technology with intellectual property, will fill the blank in the country with high-quality R&D results and service.
Benefit Analysis: Plan to finish the stability study of kits in 2014 and enter the examination and approval of trial production phase. Go into production and launch on the market in the end of 2015. With expected production capacity of 20 thousand breast cancer detection kits, 30 thousand gastric cancer detection kits and 30 thousand liver cancer detection kits each year. Annual sales of 96 million, profits of 20 million and revenue of 25 million are also expected. We will continue working on the R&D of Lung cancer detection kit and Cervical cancer detection kits.
General Description of Chinese Sponsor: Guan emerging industries demonstration zone is founded by provincial government in March, 2011. In ambition to create industrial clusters of astronautical technology, biological medicine, information technology and High-end Equipment Manufacturing.
Cooperative Form: joint venture or cooperative
Contact Person: Liang Jian Yan
Tel:13370315920
Fax: 0086-316-5925370 
Address: No.78, Six HaiBin road, bonded area, Port of Tianjin
E-mail:gaxxcysfq@126.com

Hosted by People’s Government of Langfang City
Undertaken by Office of People’s Government of Langfang City and Development & Reform Commission of Langfang City
Developed and Maintained by the Economic Information Center of Langfang City
Translated by Good Friends Translation Service Co., Ltd. of Langfang City